No-carrier-added versus carrier-added 123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 4, 2006, Pages 483-490

  Verberne, Hein J ^a   De Bruin, Kora ^a   Habraken, Jan B A ^a   Somsen, G Aernout ^b   Eersels, Jos L H ^c   Moet, Frits ^d   Booij, Jan ^a   Van Eck Smit, Berthe L F ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Mallinckrodt Medical   (Netherlands)

Author keywords

Iodine 123; Metaiodobenzylguanidine; Myocardial; No carrier added; Sympathetic nerve activity

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DESIPRAMINE; PHENOXYBENZAMINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG UPTAKE; HEART MUSCLE CELL; HEART STIMULATION; MALE; NONHUMAN; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; SYMPATHETIC NERVE;

3-IODOBENZYLGUANIDINE; ANIMALS; FEASIBILITY STUDIES; HEART; ISOTOPE LABELING; MALE; METABOLIC CLEARANCE RATE; MYOCARDIUM; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; TISSUE DISTRIBUTION;

EID: 33645869293     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-0022-1     Document Type: Article

References (41)

1. Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol 2002;9:75-94
2. 123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure. Heart 1996;76:218-22
3. de Milliano PA, de Groot AC, Tijssen JG, Eck-Smit BL, Van Zwieten PA, Lie KI. Beneficial effects of metoprolol on myocardial sympathetic function: evidence from a randomized, placebo-controlled study in patients with congestive heart failure. Am Heart J 2002;144:E3
4. Eichhorn EJ, McGhie AL, Bedotto JB, Corbett JR, Malloy CR, Hatfield BA, et al. Effects of bucindolol on neurohormonal activation in congestive heart failure. Am J Cardiol 1991; 67:67-73
5. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, et al. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. J Nucl Med 2002;43:1279-85
6. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, et al. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol 2003;41:574-81
7. Erol-Yilmaz A, Verberne HJ, Schrama TA, Hrudova J, DE Winter RJ, VAN Eck-Smit BL, et al. Cardiac resynchronization induces favorable neurohumoral changes. Pacing Clin Electrophysiol 2005;28:304-10
8. Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991;350:350-4
9. Iversen LL. The uptake of catecholamines at high perfusion concentrations in the rat isolated heart: a novel catecholamine uptake process. Br J Pharmacol 1965;25:18-33
10. 123I]iodobenzylguanidine in isolated rat heart. Nucl Med Biol 1995;22:1-12
11. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987;28:1625-36
12. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620-4
13. Rabinovitch MA, Rose CP, Schwab AJ, Fitchett DH, Honos GN, Stewart JA, et al. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993;34:589-600
14. Dae MW, O'Connell JW, Botvinick EH, Ahearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989;79:634-44
15. Fagret D, Wolf JE, Vanzetto G, Borrel E. Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. J Nucl Med 1993;34:57-60
16. Mangner TJ, Wu JL, Wieland DM. Solid-phase exchange radioiodination of aryl iodides. Facilitation by ammonium sulfate. J Organic Biochem 1982;47:1484-8
17. 123I] iodobenzylguanidine: synthesis and preliminary evaluation. Nucl Med Biol 1995;22:61-4
18. Eersels JHL, Travis MJ, Herscheid JDM. Manufacturing 1-123-labelled radiopharmaceuticals. pitfalls and solutions. J Label Compd Radiopharm 2005;48:241-57
19. Habraken JB, de BK, Shehata M, Booij J, Bennink R, van Eck Smit BL, et al. Evaluation of high-resolution pinhole SPECT using a small rotating animal. J Nucl Med 2001;42:1863-9
20. Sohlberg A, Lensu S, Jolkkonen J, Tuomisto L, Ruotsalainen U, Kuikka JT. Improving the quality of small animal brain pinhole SPECT imaging by bayesian reconstruction. Eur J Nucl Med Mol Imaging 2004;31:986-94
21. Tachikawa H, Kodama M, Watanabe K, Takahashi T, Ma M, Kashimura T, et al. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy. Circulation 2005;111:894-9
22. Kelley SP, Grota LJ, Felten SY, Madden KS, Felten DL. Norepinephrine in mouse spleen shows minor strain differences and no diurnal variation. Pharmacol Biochem Behav 1996;53:141-6
23. Cano G, Sved AF, Rinaman L, Rabin BS, Card JP. Characterization of the central nervous system innervation of the rat spleen using viral transneuronal tracing. J Comp Neurol 2001;439:1-18
24. Farahati J, Bier D, Scheubeck M, Lassmann M, Schelper LF, Grelle I, et al. Effect of specific activity on cardiac uptake of iodine-123-MIBG. J Nucl Med 1997;38:447-51
25. 123I-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias. Nucl Med Commun 1999;20:537-45
26. 123I]iodobenzylguanidine for myocardial scintigraphy. Eur J Nucl Med 2000;27:302-7
27. Chen NH, Reith ME, Quick MW. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch 2004;447:519-31
28. Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Arch 2004;447:666-76
29. Grundemann D, Schechinger B, Rappold GA, Schomig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1998;1:349-51
30. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, et al. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 1998;273:32776-86
31. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 2001;91:35-62
32. Burckhardt G, Wolff NA. Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 2000;278:F853-66
33. Hume SP, Gunn RN, Jones T. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur J Nucl Med 1998;25:173-6
34. Ungerer M, Chlistalla A, Richardt G. Upregulation of cardiac uptake 1 carrier in ischemic and nonischemic rat heart. Circ Res 1996;78:1037-43
35. Kiyono Y, Iida Y, Kawashima H, Ogawa M, Tamaki N, Nishimura H, et al. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats. Eur J Nucl Med Mol Imaging 2002;29:999-1005
36. Leineweber K, Seyfarth T, Brodde OE. Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats. Br J Pharmacol 2000;131:1438-44
37. Mardon K, Montagne O, Elbaz N, Malek Z, Syrota A, Dubois-Rande JL, et al. Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. J Nucl Med 2003;44:1459-66
38. 111In-labeled T-lymphocyte homing in experimental colitis. J Nucl Med 2004;45:1759-65
39. Vanhove C, Lahoutte T, Defrise M, Bossuyt A, Franken PR. Reproducibility of left ventricular volume and ejection fraction measurements in rat using pinhole gated SPECT. Eur J Nucl Med Mol Imaging 2005;32:211-20
40. 123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. Eur Neuropsychopharmacol 2004;14:185-9
41. Hara K, Yanagihara N, Minami K, Ueno S, Toyohira Y, Sata T, et al. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn Schmiedebergs Arch Pharmacol 1998;358:328-33